LAKESHA HIGH: Open Payments
NPI 1699143347 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 36 payments from 13 companies in 2025. Trend: 2023 $738 · 2024 $665 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $207 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Fresenius Kabi USA, LLC | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: Rybelsus, Ozempic, MOUNJARO, JARDIANCE, FARXIGA, SPRAVATO, Heplisav-B, TZIELD.
Industry payments across GA — which companies pay providers there.
